{
    "2020-07-10": [
        [
            {
                "time": "",
                "original_text": "华大基因：北京“火眼”实验室完成超120万人份核酸样本检测",
                "features": {
                    "keywords": [
                        "华大基因",
                        "火眼实验室",
                        "核酸检测",
                        "疫情防控"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "医疗服务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "新冠肺炎检测板块大涨4%，东方生物、美康生物、迪安诊断、华大基因等集体飙涨",
                "features": {
                    "keywords": [
                        "新冠肺炎检测",
                        "板块上涨",
                        "东方生物",
                        "美康生物",
                        "迪安诊断",
                        "华大基因"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药",
                        "医疗服务"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}